Skip to main content

Table 4 Multivariate analysis: risk factors associated with VRE acquisition

From: Hospital acquired vancomycin resistant enterococci in surgical intensive care patients – a prospective longitudinal study

Risk factors (p ≤ 0.05)

Odds Ratio

95% CI

Duration of stay

0.90

0.84–0.96

Long-term-dialysis

0.08

0.01–1.10

Flucloxacillin treatment

0.09

0.01–0.60

Piperacillin/tazobactam treatment

0.24

0.05–1.13